Insider · CIK 0001861519
Carmine N. Stengone
Files at KPRX (KIORA PHARMACEUTICALS INC), CTNM (Contineum Therapeutics, Inc.). First filing Sep 8, 2026, latest Sep 8, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CTNM: Contineum Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 1Weak | Contineum Therapeutics, Inc. | $41k 2,500 shares | -13% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | CTNM Contineum Therapeutics, Inc. | MOption exercise Class A Common Stock10b5-1 | +2,500 | $1.01 | $2,525 | 19,717 | 34 d ago |
| Sep 8, 2026 | CTNM Contineum Therapeutics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -2,500 | $16.46 | $41k | 17,217 | 34 d ago |
| Sep 8, 2026 | CTNM Contineum Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 274,430 | 34 d ago |
| Apr 1, 2025 | KPRX KIORA PHARMACEUTICALS INC | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Apr 2, 2025 |
| Jan 31, 2025 | CTNM Contineum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Jan 31, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.